Atossa Therapeutics appoints CFO to support commercial transition
Source: SeekingAlpha
2025-10-14 08:12:57 ET
More on Atossa Therapeutics
- Seeking Alpha’s Quant Rating on Atossa Therapeutics
- Historical earnings data for Atossa Therapeutics
- Financial information for Atossa Therapeutics
Read the full article on Seeking Alpha
For further details see:
Atossa Therapeutics appoints CFO to support commercial transition
Atossa Therapeutics Inc.
NASDAQ: ATOS
ATOS Trading
-2.78% G/L:
$5.065 Last:
13,349 Volume:
$5.16 Open:
ATOS Latest News
May 14, 2026 08:30:00 am
Atossa Therapeutics to Host Virtual KOL Event Featuring Dr. Laura Esserman to Discuss Development of (Z)-Endoxifen in ER-Positive Breast Cancer
May 08, 2026 08:45:00 am
Atossa Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
ATOS Stock Data
$42,239,054
7,796,787
11.03%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
